These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 4852984)

  • 21. [Progressive facial hyperpigmentation].
    Blumeyer A; Röwert-Huber J; Nast A; Reidel U
    Hautarzt; 2016 Nov; 67(11):922-924. PubMed ID: 27393085
    [No Abstract]   [Full Text] [Related]  

  • 22. Hydroquinone-induced exogenous ochronosis in Chinese--two case reports and a review.
    Tan SK; Sim CS; Goh CL
    Int J Dermatol; 2008 Jun; 47(6):639-40. PubMed ID: 18477169
    [No Abstract]   [Full Text] [Related]  

  • 23. [LEUCOMELANODERMA CAUSED BY HYDROQUINONE].
    ZAMITH VA
    Rev Assoc Med Bras; 1965 Feb; 11():45-6. PubMed ID: 14314079
    [No Abstract]   [Full Text] [Related]  

  • 24. [Minor symptoms in family medicine; chloasma or 'pregnancy mask'].
    Menke HE; Westerhof W
    Ned Tijdschr Geneeskd; 1995 Dec; 139(51):2698. PubMed ID: 8569877
    [No Abstract]   [Full Text] [Related]  

  • 25. Hydroquinone--a harmful agent.
    Fernandes D
    S Afr Med J; 2000 Sep; 90(9):829. PubMed ID: 11081118
    [No Abstract]   [Full Text] [Related]  

  • 26. Systemic complications of the cosmetic use of skin-bleaching products.
    Mahé A; Ly F; Perret JL
    Int J Dermatol; 2005 Oct; 44 Suppl 1():37-8. PubMed ID: 16187958
    [No Abstract]   [Full Text] [Related]  

  • 27. Aesthetic problems associated with the cosmetic use of bleaching products.
    Ly F; Soko AS; Dione DA; Niang SO; Kane A; Bocoum TI; Dieng MT; Ndiaye B
    Int J Dermatol; 2007 Oct; 46 Suppl 1():15-7. PubMed ID: 17919199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Irreversible toxic depigmentation. Observations following use of hydroquinonemonobenzylether-containing skin bleaching preparations].
    Heilgemeir GP; Balda BR
    MMW Munch Med Wochenschr; 1981 Jan; 123(2):47-8. PubMed ID: 6782448
    [No Abstract]   [Full Text] [Related]  

  • 29. Foot pigmentation in Blacks.
    Freinkel AL; Rippey JJ
    S Afr Med J; 1976 Dec; 50(55):2160-1. PubMed ID: 1013871
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cosmetic and dermatology: bleaching creams.
    Engasser PG; Maibach HI
    J Am Acad Dermatol; 1981 Aug; 5(2):143-7. PubMed ID: 7021611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Melanosis after prolonged chlorpromazine therapy.
    Robins AH
    S Afr Med J; 1975 Aug; 49(37):1521-4. PubMed ID: 1162531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chronic hydroquinone poisoning of the skin from skin-lightening cosmetics. A South African epidemic of ochronosis of the face in dark-skinned individuals.
    Findlay GH; de Beer HA
    S Afr Med J; 1980 Feb; 57(6):187-90. PubMed ID: 7361208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cutaneous reactions to topical application of hydroquinone. Results of a 6-year investigation.
    Bentley-Phillips B; Bayles MA
    S Afr Med J; 1975 Aug; 49(34):1391-5. PubMed ID: 1162515
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complications of cosmetic skin bleaching in Africa].
    Morand JJ; Ly F; Lightburn E; Mahé A
    Med Trop (Mars); 2007 Dec; 67(6):627-34. PubMed ID: 18300529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The melanocyte: an essential link in hydroquinone-induced ochronosis.
    Hull PR; Procter PR
    J Am Acad Dermatol; 1990 Mar; 22(3):529-31. PubMed ID: 2312837
    [No Abstract]   [Full Text] [Related]  

  • 36. Cosmetic ochronosis caused by bleaching creams containing 2% hydroquinone.
    Weiss RM; del Fabbro E; Kolisang P
    S Afr Med J; 1990 Apr; 77(7):373. PubMed ID: 2321111
    [No Abstract]   [Full Text] [Related]  

  • 37. Pigment anomalies encountered in the Transkei.
    Rose EF
    S Afr Med J; 1974 Nov; 48(57):2345-7. PubMed ID: 4432185
    [No Abstract]   [Full Text] [Related]  

  • 38. Skin lightening and its complications among African people living in Paris.
    Petit A; Cohen-Ludmann C; Clevenbergh P; Bergmann JF; Dubertret L
    J Am Acad Dermatol; 2006 Nov; 55(5):873-8. PubMed ID: 17052496
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is Bindi-induced depigmentation common in patients predisposed to vitiligo?
    Bose SK
    J Dermatol; 1994 May; 21(5):370-1. PubMed ID: 8051327
    [No Abstract]   [Full Text] [Related]  

  • 40. Leukoderma from hydroquinone.
    Romaguera C; Grimalt F
    Contact Dermatitis; 1985 Mar; 12(3):183. PubMed ID: 3995954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.